Alpha Cognition Inc. (ACOG)
Last updated: 2026-10-23 21:18:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Alpha Cognition Inc. (ACOG) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $8.36, with a market capitalization of $186.85M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.50 to $10.14. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$186.85M | |
$8.30 | |
$11.54 | |
$3.75 | |
$8.31 | |
126.28K | |
122.99K | |
-- | |
$10.14 | |
$4.50 | |
-- | |
-- |
Alpha Cognition Inc. (ACOG) After-Hours Stock Price
Alpha Cognition Inc. (ACOG) is trading at $8.36 in after-hours trading as of 2026-10-23 20:26:00, up 0.60% ($0.05) from the regular-session close of $8.31.
After-hours trading shows how investors are pricing ACOG after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Alpha Cognition Inc. (ACOG) 7-Day Stock Price Change
Over the past seven days, Alpha Cognition Inc. (ACOG) moved from $8.65 to $8.36, representing a decline of 3.38% ($0.29).
The stock traded between $8.02 and $8.94 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 121.75 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
ACOG 52-Week Price Position
Position in Range: 68.4%
ACOG is currently trading at $8.36, placing it 68.4% of the way from its 52-week low of $4.50 to its 52-week high of $10.14. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Alpha Cognition Inc. (ACOG)?
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
Alpha Cognition Inc. Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 71 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Alpha Cognition Inc. (ACOG) Stock on MEXC
Eligible investors can buy real shares of Alpha Cognition Inc. (ACOG) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Alpha Cognition Inc. (ACOG) stock price today?
2.Is ACOG stock going up or down today?
3.What is ACOG pre-market price?
4.What is ACOG after-hours price?
5.Is ACOG stock trading now?
6.Where does ACOG sit relative to its 52-week high and low?
7.What sector is Alpha Cognition Inc. in?
8.What is Alpha Cognition Inc.'s market capitalization and where is it listed?
9.How is ACOG valued in terms of P/E ratio and EPS?
10.Does Alpha Cognition Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ACOG Stock Calculator
Estimate the value between ACOG shares and USD.
ACOG Shares to USD
1.00 ACOG shares = 8.358 USD
Calculations are estimates based on the latest available price and are for reference only.


